Tutorials › Statistical Genetics › Why the Nearest Gene Is Not Necessarily the Target

Locus-Level Functional Annotation · Tutorial 674 of 989

Why the Nearest Gene Is Not Necessarily the Target

Learn to distinguish the nearest gene by genomic position from a gene supported by regulatory evidence, and to describe that evidence without overstating what it proves.

Advanced 10 min read

What You'll Learn

  • Define nearest-gene attribution using transcription start sites and genomic distance
  • Explain why gene orientation does not identify a regulatory target
  • Evaluate distal enhancer-to-promoter links against a proximity-only assignment
  • Recognize how multiple promoters can change the interpretation of a locus
  • Compare tissue-matched and mismatched contact evidence cautiously
  • State what the evidence supports without treating a regulatory link as proof of causation

Introduction

When a genetic locus is close to a gene, that gene is an obvious candidate. But “closest” describes a position on a chromosome; it does not, by itself, identify the gene through which a variant acts. A regulatory element can contact and influence a more distant promoter, and a locus can have different plausible targets in different tissues. Gene orientation and promoter choice add further reasons that a simple nearest-gene label can mislead.

The aim here is not to replace one automatic assignment rule with another. It is to diagnose when proximity is a weak or incomplete basis for attribution, and to state what regulatory evidence does—and does not—support. A link from a variant-containing regulatory element to a gene is evidence for a candidate relationship, not proof that the variant changes that gene or causes a trait through it.

What “Nearest Gene” Measures

Definition: Under a nearest-transcription-start-site rule, the nearest gene to a variant is the gene whose transcription start site (TSS) has the smallest absolute genomic-coordinate distance from the variant. If the variant is at coordinate \(v\) and a gene has TSS coordinate \(t\), their distance is \(d=|v-t|\). This rule is positional: it uses coordinates, not evidence that the gene is regulated by the variant.

An annotation may instead define “nearest gene” by distance to the gene body, such as the shortest distance to any base in the gene’s genomic span. Those conventions can yield different answers, especially when a variant falls within a gene or when neighboring genes overlap. A report should therefore say which distance was used. In the examples below, nearest-gene distances are measured to the nearest annotated TSS.

Coordinates must refer to the same genome build, and the candidate genes and regulatory elements must be annotated on that build. A distance calculated across mismatched coordinates is not meaningful. Even with correct coordinates, distance is only a description of genomic layout. It does not tell us whether the variant overlaps a regulatory element, whether that element is active in a relevant tissue, or which promoter it may regulate.

Orientation Is Not a Target Assignment

A gene’s strand determines the direction in which its sequence is transcribed. On the plus strand, transcription proceeds toward increasing genomic coordinates; on the minus strand, it proceeds toward decreasing coordinates. A promoter is generally near a gene’s TSS, but “upstream” depends on the gene’s strand: it is toward lower coordinates for a plus-strand gene and toward higher coordinates for a minus-strand gene.

This matters when interpreting a locus between genes. A variant can be upstream of one gene and downstream of another, but those labels do not establish which gene is regulated. Regulatory elements can act over a distance and need not lie on the promoter’s upstream side. Nor does a promoter’s orientation reveal which enhancer contacts it. Orientation helps interpret the map; it is not a substitute for functional evidence.

Worked Example: A Closer TSS Does Not Settle the Target

Hypothetical data. A candidate variant is at coordinate 1,000,000. Gene A is on the plus strand with a TSS at 998,000. Gene B is on the minus strand with a TSS at 1,015,000. An accessible element containing the variant is observed in a relevant cell type and has a promoter contact with Gene B. Assume the coordinates are from the same genome build and the contact assay was performed in that cell type.

By the nearest-TSS rule, the distances are:

$$ d_A=|1{,}000{,}000-998{,}000|=2{,}000\text{ bp} $$
$$ d_B=|1{,}000{,}000-1{,}015{,}000|=15{,}000\text{ bp} $$

Gene A is closer by 13,000 bp, so a proximity-only annotation would label Gene A as nearest. But the variant-containing element has a measured contact with Gene B’s promoter in the relevant cell type. Gene B is therefore a plausible regulatory target despite its more distant TSS. The contact supports that candidate link; it does not, by itself, show that the variant changes Gene B’s expression. Gene A remains the nearest gene, while the evidence makes it inappropriate to treat that positional label as a settled target assignment.

The strand information does not reverse this conclusion. Gene A’s promoter is at lower coordinates because it is on the plus strand, while Gene B’s promoter is at higher coordinates because it is on the minus strand. Neither orientation decides which promoter the element contacts.

Distal Links and Promoter Choice

A regulatory-element-to-gene link changes the question from “Which gene is closest?” to “Which promoter, if any, is supported as a potential target of the element?” Earlier material on promoters, enhancers, chromatin accessibility, and chromatin contact provides the relevant evidence types. An enhancer-like chromatin state can support the interpretation that a region is regulatory; a contact can support a physical relationship between that region and a promoter. The value of those observations depends partly on whether they come from the tissue or cell type relevant to the locus.

A gene can also have multiple promoters and TSSs. If the variant-containing element contacts one promoter, it is not enough to say only that it “links to the gene” when the promoter distinction matters. Different promoters can be active in different tissues or produce different transcript forms. A nearest-TSS calculation may select one promoter because it is closest, while regulatory evidence points to another promoter of the same gene—or to a promoter of a different gene.

Worked Example: A Gene With Two Promoters

Hypothetical data. A variant at coordinate 5,000,000 lies in an enhancer-like element active in a relevant tissue. Gene C has two annotated promoters, at 4,990,000 and 5,040,000. Gene D has one promoter at 5,006,000. A contact assay in the relevant tissue links the element to Gene C’s promoter at 5,040,000; no contact is detected to the other two promoters. Assume all coordinates are on the same genome build and the promoter annotations are appropriate for the tissue.

Using the nearest-TSS convention, the distances are:

$$ d_{\text{C,1}}=|5{,}000{,}000-4{,}990{,}000|=10{,}000\text{ bp} $$
$$ d_{\text{C,2}}=|5{,}000{,}000-5{,}040{,}000|=40{,}000\text{ bp} $$
$$ d_{\text{D}}=|5{,}000{,}000-5{,}006{,}000|=6{,}000\text{ bp} $$

Gene D has the nearest TSS, at 6,000 bp. But the observed contact is to Gene C’s second promoter, 40,000 bp away, not to Gene D’s promoter or Gene C’s first promoter. The evidence therefore supports considering a specific enhancer-to-promoter link involving Gene C, even though Gene D wins the proximity comparison. It does not establish that the variant affects Gene C, and the lack of a detected contact to the other promoters is not proof that no interaction exists. The precise conclusion is that the data provide a tissue-matched contact observation for the element and Gene C’s second promoter.

Why Tissue Matching Matters

Regulatory activity and chromatin contacts can vary by tissue and cell type. A contact observed in a cell type relevant to the phenotype is generally more pertinent to interpreting the locus than a contact observed only in an unrelated cell type. This is a relevance judgment, not a claim that a contact in a relevant tissue proves a mechanism. Likewise, failure to observe a contact can reflect assay coverage or sensitivity, as well as a genuinely absent interaction.

When comparing evidence, keep its source and context visible. An enhancer mark in one tissue and a contact in another do not jointly demonstrate that the element is active and connected to the promoter in the same biological context. If evidence comes from different tissues, describe that mismatch rather than combining the observations as though they were a single coherent chain. The earlier material on tissue and cell-type matching and missingness is useful here: “not observed” and “observed to be absent” are not interchangeable.

Worked Example: A Contact in the Wrong Tissue

Hypothetical data. A variant lies in an accessible, enhancer-like element in a relevant immune-cell type. The nearest TSS is Gene E, 4,000 bp away. Gene F’s promoter is 30,000 bp away. A contact from the element to Gene F’s promoter is observed in a liver-derived cell line, but no contact is available for the immune-cell type. Assume the variant and element coordinates are correctly mapped and the tissue labels are accurate.

The proximity calculation is:

$$ d_E=4{,}000\text{ bp},\qquad d_F=30{,}000\text{ bp} $$

Gene E is the nearest TSS. The contact observation makes Gene F worth considering, but it comes from a cell type different from the one in which the element is reported to be active. It therefore does not establish a relevant-tissue link between the element and Gene F. A careful annotation would say that Gene E is nearest by position, that a contact to Gene F was reported in a liver-derived cell line, and that matching contact evidence in the relevant immune-cell type is unavailable. It would be unjustified either to call Gene E the proven target or to treat the liver contact as decisive evidence for Gene F.

A Short Justification: Distance Alone Cannot Identify a Target

The limitation of nearest-gene attribution follows directly from how the rule is defined. Let \(G\) be the set of annotated genes and \(t_g\) the TSS coordinate chosen for gene \(g\). The rule returns:

$$ g_{\mathrm{near}}=\operatorname*{arg\,min}_{g\in G}|v-t_g| $$

The inputs to this calculation are the variant coordinate and the TSS coordinates. There is no term for enhancer activity, contact, tissue, or promoter usage. Consequently, two loci with the same variant and TSS coordinates receive the same nearest-gene label even if regulatory evidence differs between them. For example, adding a tissue-matched contact from a variant-containing enhancer to a more distant promoter does not change any \(|v-t_g|\), and therefore cannot change \(g_{\mathrm{near}}\). It does change the functional evidence available for interpreting the locus. Thus, the nearest-gene rule can be a useful positional summary, but it cannot, on its own, establish a regulatory target.

A Practical Diagnostic

When a nearby gene is being treated as the target, check whether the conclusion depends only on its distance. A disciplined review separates positional description from functional support:

1
State the positional rule.
Record whether proximity is measured to a TSS or a gene body, and report the coordinate build and relevant distance.
2
Check the locus context.
Identify nearby genes, their strand orientations, and their annotated promoters. Do not infer a target from upstream or downstream position alone.
3
Inspect regulatory evidence.
Ask whether the variant overlaps a supported regulatory element and whether that element has evidence linking it to a particular promoter, including a more distant one.
4
Check tissue and promoter specificity.
Record the tissue or cell type for each observation and distinguish among multiple promoters of the same gene where the evidence allows.
5
Phrase the conclusion at the evidence level.
Separate “nearest gene” from “candidate target supported by regulatory evidence.” Note missing or mismatched evidence, and do not describe a link as proof of causal action.

Common Mistakes and Why the Distinction Matters

Nearest-gene attribution is convenient because it is reproducible and easy to calculate. Its convenience can make it seem stronger than it is. Treating the nearest gene as the target without checking regulatory evidence can misdirect follow-up experiments, obscure a distal candidate, or conceal a promoter-specific interpretation. The correction is not to assume that the farthest contacted gene must be correct: contacts and regulatory annotations also have limitations. Instead, describe the positional result and the functional evidence separately.

  • Wrong reasoning: “The variant is closest to Gene A, so Gene A is the target.” Correction: It is nearest to Gene A under a stated distance rule; target status requires other relevant evidence.
  • Wrong reasoning: “The variant is upstream of Gene B, so it regulates Gene B.” Correction: Upstream depends on strand orientation and does not establish a regulatory link.
  • Wrong reasoning: “The element contacts Gene C, so the variant definitely changes Gene C.” Correction: A contact supports a candidate relationship, but does not prove that the variant alters regulation or causes a trait through that gene.
  • Wrong reasoning: “There is no contact in the available data, so the gene cannot be targeted.” Correction: A missing observation may reflect incomplete coverage or assay limitations.
  • Wrong reasoning: “A contact in any cell type is equally informative.” Correction: Report the tissue and judge its relevance to the biological question.
Key takeaway: “Nearest” is a positional label, not a functional conclusion. Distal regulatory links, gene orientation, multiple promoters, and tissue-specific evidence can all change which genes are plausible candidates, while leaving the nearest-gene calculation unchanged.

Check Your Understanding

For each question, distinguish what follows from position alone from what requires functional evidence.

  1. A variant is 3,000 bp from Gene A’s TSS and 20,000 bp from Gene B’s TSS. What can be concluded under a nearest-TSS rule, and what cannot be concluded?
  2. Why does a gene’s strand orientation affect the meaning of “upstream” without identifying a regulatory target?
  3. A variant-containing element contacts a promoter 50,000 bp away in a relevant tissue, while another gene has a TSS 5,000 bp away. How should the two observations be described?
  4. A gene has two promoters, and an enhancer contact is observed only for the farther promoter. What detail should a careful annotation preserve?
  5. What is the limitation of interpreting a contact observed in an unrelated cell type as evidence for a target in the tissue relevant to the phenotype?
Clinical Biostats